Sotorasib significantly decreased the ratio of the GTP-bound form of KRAS/G12C but not KRAS/wild-type and other cancer-associated KRAS mutants such as KRAS/G12D, G12V, and G13D. The gene discussed is KRAS; the disease is cancer.